Published in AIDS Weekly, November 20th, 1995
Studies show that Invirase can work together with conventional HIV therapies - nucleoside analogues such as AZT (ZDV) and HIVID (ddC) - but has fewer side effects and is well tolerated by patients. Unlike nucleoside analogues, which inhibit the enzyme reverse transcriptase, Invirase blocks the enzyme proteinase. Both enzymes are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.